US 2021/0171464 A1Published application

Amorphous form of pimavanserin hemitartrate

AssigneeOlon S.P.A.

InventorsMattia BERTOLOTTI, Jacopo BONANOMI, Barbara NOVO

Life of this patent

Estimating the term…

Disclosed is the amorphous form of pimavanserin* hemitartrate, the process for its preparation, and pharmaceutical formulations containing it.

Dependent claims

Amorphous solid form of pimavanserin hemitartrate.

Dependencies are inferred from the claim text.

C07D 211/58
Nitrogen atoms: attached in position 4
A61P 25/28
Drugs for disorders of the nervous system: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents,…
C07B 2200/13
Indexing scheme relating to specific properties of organic compounds: crystalline forms, e.g. polymorphs
C07D
Heterocyclic compounds

No related US applications are recorded in the indexed filing history.

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

Loading patent…